Merck and Ridgeback Biotherapeutics Provide Update on New Clinical and Non-Clinical Studies of LAGEVRIO™ (molnupiravir)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ROIV
6. AAPL
7. HOOD
8. QCOM
9. ACN
10. AZN

Go back to Merck and Ridgeback Biotherapeutics Provide Update on New Clinical and Non-Clinical Studies of LAGEVRIO™ (molnupiravir)
Merck & Co. (NYSE: MRK) Delayed: 148.46 -1.87 (1.24%)
Previous Close $150.33    52 Week High $65.46 
Open $148.41    52 Week Low $47.97 
Day High $149.60    P/E 100.99 
Day Low $146.28    EPS $1.47 
Volume 11,187,248